US Kids Represent a Psychiatric Goldmine

WHY are we drugging our children?


From the article:

Saturday 12 December 2009
by: Evelyn Pringle, t r u t h o u t | Report

Prescriptions for psychiatric drugs increased 50 percent with children in the US, and 73 percent among adults, from 1996 to 2006, according to a study in the May/June 2009 issue of the journal Health Affairs. Another study in the same issue of Health Affairs found spending for mental health care grew more than 30 percent over the same ten-year period, with almost all of the increase due to psychiatric drug costs.

On April 22, 2009, the US Agency for Healthcare Research and Quality reported that in 2006 more money was spent on treating mental disorders in children aged 0 to 17 than for any other medical condition, with a total of $8.9 billion. By comparison, the cost of treating trauma-related disorders, including fractures, sprains, burns, and other physical injuries, was only $6.1 billion.

In 2008, psychiatric drug makers had overall sales in the US of $14.6 billion from antipsychotics, $9.6 billion off antidepressants, $11.3 billion from antiseizure drugs and $4.8 billion in sales of ADHD drugs, for a grand total of $40.3 billion.

The path to child drugging in the US started with providing adolescents with stimulants for ADHD in the early 80s. That was followed by Prozac in the late 80s, and in the mid-90s drug companies started claiming that ADHD kids really had bipolar disorder, coinciding with the marketing of epilepsy drugs as "mood stablizers" and the arrival of the new atypical antipsychotics.

Parents can now have their kids declared disabled due to mental illness and receive Social Security disability payments and free medical care, and schools can get more money for disabled kids. The bounty for the prescribing doctors and pharmacies is enormous and the CEOs of the drug companies are laughing all the way into early retirement.

Psychiatric Drugs Explained

During an interview with Street Spirit in August 2005, investigative journalist and author of "Mad in America," Robert Whitaker, described the dangers of psychiatric drugs. "When you look at the research literature, you find a clear pattern of outcomes with all these drugs," he said, "you see it with the antipsychotics, the antidepressants, the anti-anxiety drugs and the stimulants like Ritalin used to treat ADHD."

"All these drugs may curb a target symptom slightly more effectively than a placebo does for a short period of time, say six weeks," Whitaker said. However, what "you find with every class of these psychiatric drugs is a worsening of the target symptom of depression or psychosis or anxiety, over the long term, compared to placebo-treated patients."

"So even on the target symptoms, there's greater chronicity and greater severity of symptoms," he reports, "And you see a fairly significant percentage of patients where new and more severe psychiatric symptoms are triggered by the drug itself."

Whitaker told Street Spirit that the rate of Americans disabled by mental illness has skyrocketed since Prozac came on the market in 1987, and reports: (1) the number of mentally disabled people in the US has been increasing at a rate of 150,000 people per year since 1987, (2) that represents an increase of 410 new people per day and (3) the disability rate has continued to increase and one in every 50 Americans is disabled by mental illness.

The statistics above beg the question of how could this happen when the so-called new generation of "wonder drugs" arrived on the market during the exact same time period. The truth is, the "wonder drugs" cause most of the bizarre behaviors listed by doctors to warrant a mental illness disability.

Link


To read more about the astonishing rise in mental illness in America since the introduction of psychiatric drugs, go to this PDF by Robert Whitaker: Anatomy of an Epidemic,


Another valuable in-depth resource on these matters is Vera Hassner Sharav's AHRP - Alliance for Human Research Protection - here.

To see our previous posts and links about the drugging of children, search for "children drugs" in our SEARCH box in the upper right hand corner of the blog.

Nicotinic receptor - and Niacin

"AstraZeneca, the Anglo-Swedish pharmaceutical group, today announced its biggest deal of the year with a plan to tap into the global market for antidepressants, estimated to be worth more than $20bn (£12bn).

The company, headed by David Brennan, is teaming up with US biotech specialist Targacept, which is developing an antidepressant drug that works on the brain in a different way to selective serotonin reuptake inhibitors (SSRIs) such as Prozac and Seroxat, known as Paxil in the United States.

Under the terms of the transaction, AstraZeneca will pay Targacept $200m and a further $1bn if the medicine gets regulatory clearance and meets certain sales targets. The drug will undergo final clinical trials over the next year and is expected to be filed with the US regulator, the Food and Drug Administration, in 2012.

The licensing agreement means that Brennan's company will contribute to further development costs and market the drug worldwide, providing it gets regulatory clearance.

According to AstraZeneca, the deal is significant because the new product could offer a new alternative to millions of people whose depression fails to respond to SSRIs. A recent study found that SSRIs did not work for up to two-thirds of patients."

Link


"Targacept, Inc. is a biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics(TM), a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system. Our NNR Therapeutics selectively target neuronal nicotinic receptors, or NNRs. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity.

We currently have a robust clinical-stage product pipeline and multiple preclinical product candidates. Our most advanced product candidates are in development for major depressive disorder, attention deficit/hyperactivity disorder, Alzheimer’s disease and cognitive dysfunction in schizophrenia.

Targacept is located in Winston-Salem, North Carolina."
Targacept

Nicotinic receptors indicate NIACIN - Vitamin B3 - which has health-restoring effects in ALL of the conditions
mentioned above. If Niacin does no harm and is cheap, why not try B3 first?




Image: The Emperor's New Clothes

NATURE: Pharmaceutical industry financial UNDERperformance

Pharmaceutical industry financial performance
doi:10.1038/nrd3049
Only 2 of the 14 large–cap pharmaceutical companies are predicted to have a positive net present value gap against a 5% compound annual growth rate in revenue for the period 2009–2015.

Oh noes...

Link

Game Brain

This article from Men Style/GQ is a little way off our usual Pharma trail, but certainly made us think - and wonder how many damaged brains we will see in the future in users of certain medications. The cruelty of corporate executives involved in these cases is noteworthy and clear; we do not doubt that similar coverups and indifference occur in fields other than sports.

"Let’s say you run a multibillion-dollar football league. And let’s say the scientific community—starting with one young pathologist in Pittsburgh and growing into a chorus of neuroscientists across the country—comes to you and says concussions are making your players crazy, crazy enough to kill themselves, and here, in these slices of brain tissue, is the proof. Do you join these scientists and try to solve the problem, or do you use your power to discredit them?"



"The coverage that week had been bracing and disturbing and exciting. Dead at 50. Mike Webster! Nine-time Pro Bowler. Hall of Famer. “Iron Mike,” legendary Steelers center for fifteen seasons. His life after football had been mysterious and tragic, and on the news they were going on and on about it. What had happened to him? How does a guy go from four Super Bowl rings to…pissing in his own oven and squirting Super Glue on his rotting teeth? Mike Webster bought himself a Taser gun, used that on himself to treat his back pain, would zap himself into unconsciousness just to get some sleep. Mike Webster lost all his money, or maybe gave it away. He forgot. A lot of lawsuits. Mike Webster forgot how to eat, too. Soon Mike Webster was homeless, living in a truck, one of its windows replaced with a garbage bag and tape.
...
Omalu stared at Mike Webster’s brain. He kept thinking, How did this big athletic man end up so crazy in the head? He was thinking about football and brain trauma. The leap in logic was hardly extreme. He was thinking, Dementia pugilistica? “Punch-drunk syndrome,” they called it in boxers. The clinical picture was somewhat like Mike Webster’s: severe dementia—delusion, paranoia, explosive behavior, loss of memory—caused by repeated blows to the head. Omalu figured if chronic bashing of the head could destroy a boxer’s brain, couldn’t it also destroy a football player’s brain? Could that be what made Mike Webster crazy?"

Article continues here.

The New York Times has more here.

Bipolar Disorder Secondary to Head Injury - a MEDLINE Search by Ivan K. Goldberg, M.D. can be found here.

To view healthy and sick brains at the Harvard Whole Brain Atlas, go here.

The Sports Legacy Institute is here.

Social Utility: How Much Are Grandma and Grandpa Worth?

By Dr. Russell Blaylock, author of EXCITOTOXINS - THE TASTE THAT KILLS
A thought-provoking essay. The ideas presented here apply to any individuals who are older, disabled or different.
Link
Are the prime beneficiaries of sacrifice of today's "useless eaters" not persons, society in general or even the State - but Corporations?

Trailer from LOGAN'S RUN, a 1976 sci-fi film set in a dystopia where aging persons are culled - at 30:

More on the "old killed for benefit of young" debate in the arts is here.

Another way to profit from the elderly: Retired Texas couple held in care as "incompetent" while guardian and state clean out their assets.
News link

Humor: Help Dr. Frist Find His Lost Kitty!

Link to spoof

Bill Frist medical experiments controversy

HCA scandal (Forbes)


Is your health insurance making you feel like a cat in a cage?

How Pharma Giants are Getting Rich by Calling Our Life Problems Medical Disorders

Voodoo diagnostics are major mojo for pharmaceutical corporations - and the pshrinks who prescribe.

In 1994, the DSM-IV was published to considerable acclaim, with a text revision released in 2000. A quick glance through its list of contributors is revealing. As was reported in a 2006 study, lead-authored by Lisa Cosgrove of the University of Massachusetts, 56 per cent (95 of 170) of the researchers who worked on the manual had at least one monetary relationship with a drug manufacturer between 1989 and 2004. Twenty-two per cent of these researchers received consulting income during that period, and 16 per cent were paid spokespersons for a drug company. The percentages are even higher – 100 per cent in some instances – for researchers who contributed to the manual’s subsections on psychotic disorders such as schizophrenia. While Cosgrove and her coauthors were not able to determine the percentage of researchers who received funds from the drug industry during the actual production of the DSM-IV, the chorus of protest that arose following their paper’s publication was telling. “I can categorically say,” roared the DSM-IV’s text and criteria editor, Michael First, “that drug-company influence never entered into any of the discussions, whatsoever.”

Images: Dr. John Dee, Elizabethan alchemist and magician, above; and cartoon, The Money Demon, below

FDA Throws Lifeline to Antipsychotic Pushers

Image: Klimt, Mother and Child


Mothers' Act Looms as Drug Industry Scam

FDA Throws Lifeline to Antipsychotic Pushers

By EVELYN PRINGLE

"On June 11, 2009, FDA News reported that AstraZeneca’s Seroquel, Pfizer’s Geodon and Eli Lilly’s Zyprexa atypical antipsychotics "won an FDA advisory panel’s recommendations for approval to treat schizophrenia and bipolar disorder in pediatric and adolescent patients."

"The FDA's expanded marketing approval process for antipsychotics, highly toxic drugs, is unaffected by evidence uncovered by the US Justice Department showing that the studies submitted by drug manufacturers were often flawed, if not fraudulent," says Vera Hassner Sharav, president of the Alliance for Human Research Protection, in a June 8, 2009 infomail alert.

"Rather than focus on protecting children's safety, FDA officials are doing their utmost to legitimize irresponsible, off-label prescribing of exceedingly toxic antipsychotics for children--thereby ensuring that far greater numbers of children will be victimized and die," according to Sharav.

A recent report by the consulting firm Decision Resources found antipsychotics makers spent $993,000,000 in 2006, to promote these drugs to doctors and patients, she reports. In 2008, at more than $14 billion, antipsychotic revenues topped all other classes of drugs in the US, even cholesterol and diabetes medications."

Link

P.A. Comments:
There are 29 known causes of schizophrenia, and most are easily corrected with elimination or supplementation - not antipsychotics. The sooner the public understands this, the better.
http://www.alternativementalhealth.com/articles/causesofschizophrenia.htm

Former drug rep: Pharma not in business of healing

With thanks to - http://www.myspace.com/psychtruth

Ex-Pharma Sales Reps Speaks Out - Pharma Not in Business of Health, Healing, Cures, Wellness.

Gwen Olsen spent fifteen years as a pharmaceutical sales rep working for such healthcare giants as Johnson & Johnson, Bristol-Myers Squibb, and Abbott Laboratories. She enjoyed a successful, fast-paced career until several conscious-altering experiences began awakening her to the dangers lurking in every American medicine cabinet. Her most poignant lessons, however, came as both victim and survivor of life-threatening adverse drug reactions. After leaving pharmaceutical sales in 2000, Gwen worked in the natural foods industry first as an Account Manager for Nature's Way, and then as a Regional Sales Manager for Gaia Herbs. She is currently a writer, speaker, and natural health consultant.

The United States health care system is killing Americans at an alarming rate, even though we spend over fifteen percent of the Gross National Product (GNP) on health care. According to the Journal of the American Medical Association, our health care outcomes ranked only fifteenth among twenty-five industrialized nations worldwide. Adverse effects from prescription drugs have become the third-leading killer of Americans. Only heart disease and cancer claim more lives. We trust our doctors to inform us and our government to protect us from medical malfeasance that may put profits ahead of consumer health and safety. But the fine line walked by the FDA between the interests of the pharmaceutical manufacturers and the American public has continually been crossed. The result is the unleashing of an unprecedented number of lethal drugs on the U.S. market!

Gwen Olsen learned firsthand the danger that lurks in every American's medicine cabinet, working in the pharmaceutical industry. But her most poignant education would come as a victim and, ultimately, as a survivor.

Visit Gwen's Website at

http://www.gwenolsen.com/

Confessions of an Rx Drug Pusher
God's Call to Loving Arms

http://www.amazon.com/Confessions-Rx-...

This video was produced by Psychetruth

http://www.myspace.com/psychtruth
http://www.youtube.com/psychetruth

© Copyright 2008 Gwen Olsen. All Rights Reserved.

Disease Mongering

"Driving the annual double-digit growth in the legal drug supply are a band of specialist "healthcare" PR companies working for behemoths such as Pfizer, GlaxoSmithKline, Merck and Astra Zeneca. Heading the healthcare PR league table are Edelman, Ruder Finn and Chandler Chicco Agency in the US and Medical Action Communications, Shire Health Group and Meditech Media in the UK.

"Medical education" includes cultivating and deploying sponsored "key opinion leaders" such as doctors. Patient groups too can be created or wooed to assist with "disease awareness campaigns" or provide emotionally charged testimony in favor of speedy regulatory approval of new drugs.

Other lucrative revenue streams for healthcare PR companies can include organizing events such as medical conferences that provide a platform for well-trained "product champions" to announce promising results of drug research. Such results can be reported by medical journalists--who can be hired by PR firms--in medical journals that they can create for their clients."

Link

Canadians spend $30 Billion a Year on Medications

That CAN'T be healthy.
Link
PDF
Two thoughts:
The father of medicine said "Let your food be your medicine"
and
Are we medicating for nutritional deficiencies? Do we take laxatives when extra fiber and Vitamin C would put us right?

Need, not Greed: Canadian Federation of Nurses Calls for Pharmacare

From the Canadian Federation of Nurses' Statement:

Drugs now rank second after hospitals in terms of share of total health care spending,
having overtaken spending on physicians in 1997. The share of total spending going to
drugs rose from 9.5 percent in 1985 to 16.2 percent in 2002. Spending on drugs is expected
to hit 16.7 percent of total health care spending in 2004, while spending on physicians will
be just 12.9 percent.3

The rapid rise in drug costs is primarily due to the ongoing substitution of newer, more
expensive drugs in place of existing, less expensive products. The newer drugs, in the
majority of cases, have no added benefit. Of the 117 drugs with new ingredients introduced
in Canada between 1998 and 2002, only 15 provided a substantial improvement over
existing drugs.4 The rest are “me-too” drugs that offer little or no therapeutic advances over
existing therapies but are responsible for 80 percent of the increased expenditure on drugs.5

Aggressive advertising by drug companies drives consumption of these me-too drugs.6
Apart from advertising directly to consumers, drug companies spend approximately
$30,000 per year for every doctor in Canada on drug samples, sales rep contact,
conferences, trips and giveaways.7 The influence of pharmaceutical companies on research,
education and clinical practice has also been widely documented.8 Both patients and
doctors are influenced by the onslaught,9 with the result that drug costs are skyrocketing
but health outcomes are not necessarily improving.

Pdf here

Actual Cost of Making Popular Prescription Drugs

Actual Cost Of Making These Popular Prescription Drugs
Posted November 8, 2003 thepeoplesvoice.org

From Dr. Betty Martini
From JUDICIAL REFORM INVESTIGATIONS / justice@court.to

Did you ever wonder how much it costs a drug company for the Active ingredient in prescription medications? Some people think it must cost a lot, since many drugs sell for more than $2.00 per tablet. We did a search of offshore chemical synthesizers that supply the active ingredients found in drugs approved by the FDA. As we have revealed in past issues of Life Extension, a significant percentage of drugs sold in the United States contain active ingredients made in other countries.

In our independent investigation of how much profit drug companies really make, we obtained the actual price of active ingredients used in some of the most popular drugs sold in America. The chart
here speaks for itself.

What REALLY kills Americans?

Link

Drugging Children to Keep Them Quiet

Here is a blast from Merzenich on drugs for the "bipolar child".

Video: Biological Causes of Depression

Presents information on biological causes of depression, which can include adverse effects from antidepressants, and natural help with nutrition.

How to Legally Avoid Vaccinations of All Kinds

Read about it here
And get a CDC pdf on injection ingredients here